TY - JOUR
T1 - Supine Positioning in Primary Total Hip Replacement is Associated with a Shorter Hospital Stay Than Lateral Positioning
T2 - A Retrospective Propensity-Score Matched Cohort Study
AU - Tsai, Yung Fong
AU - Hsu, Chih Yi
AU - Hsu, Wei Ti
AU - Lai, Chiung Wen
AU - Lee, Tsung Yang
AU - Huang, Tsan Wen
AU - Wu, Shao Chun
N1 - Publisher Copyright:
© 2025 Tsai et al.
PY - 2025
Y1 - 2025
N2 - Background: There is still no definite answer regarding the most advantageous patient positioning during total hip replacement (THR). We compared whether patient position (lateral vs supine) incur a difference on hospital length of stay (LOS) after primary THR. Methods: This retrospective cohort study included primary THR patients at a single tertiary center (2017–2022). THR patients prepared in the lateral decubitus position were compared to those in the supine position. Propensity score matching at a 1:4 ratio was applied to minimize selection bias. Matching covariates included age, sex, body weight, comorbidities (hypertension, diabetes), anesthesia time, and intraoperative tranexamic acid use. After matching, 990 patients were analyzed (792 lateral; 198 supine). Results: In supine group, the median LOS (5 days, IQR: 4–6) was shorter than the lateral group (5 days, IQR: 5–6; p<0.001). More supine patients were discharged before day 5 (45.5% vs 22.7%, p<0.001). Multivariate analysis revealed supine position as the strongest protective factor against long hospitalization (OR: 0.32, 95% CI: 0.23–0.46, p<0.001). Other notable predictors of long LOS included ASA ≥III (OR: 1.74), longer anaesthesia duration (OR: 1.78), and higher IV fluid administration (OR: 1.08). Patient positioning did not notably predict blood transfusion risk (OR: 1.32, p=0.144). Conclusion: THR patients in supine positioning have a substantial reduction in hospital LOS compared to patients in lateral decubitus positioning, with supine position providing a 68% reduction in risk of long hospitalization. The two groups showed no difference in blood transfusion requirements.
AB - Background: There is still no definite answer regarding the most advantageous patient positioning during total hip replacement (THR). We compared whether patient position (lateral vs supine) incur a difference on hospital length of stay (LOS) after primary THR. Methods: This retrospective cohort study included primary THR patients at a single tertiary center (2017–2022). THR patients prepared in the lateral decubitus position were compared to those in the supine position. Propensity score matching at a 1:4 ratio was applied to minimize selection bias. Matching covariates included age, sex, body weight, comorbidities (hypertension, diabetes), anesthesia time, and intraoperative tranexamic acid use. After matching, 990 patients were analyzed (792 lateral; 198 supine). Results: In supine group, the median LOS (5 days, IQR: 4–6) was shorter than the lateral group (5 days, IQR: 5–6; p<0.001). More supine patients were discharged before day 5 (45.5% vs 22.7%, p<0.001). Multivariate analysis revealed supine position as the strongest protective factor against long hospitalization (OR: 0.32, 95% CI: 0.23–0.46, p<0.001). Other notable predictors of long LOS included ASA ≥III (OR: 1.74), longer anaesthesia duration (OR: 1.78), and higher IV fluid administration (OR: 1.08). Patient positioning did not notably predict blood transfusion risk (OR: 1.32, p=0.144). Conclusion: THR patients in supine positioning have a substantial reduction in hospital LOS compared to patients in lateral decubitus positioning, with supine position providing a 68% reduction in risk of long hospitalization. The two groups showed no difference in blood transfusion requirements.
KW - blood transfusion
KW - hospital length of stay
KW - lateral position
KW - patient positioning
KW - supine position
KW - total hip replacement
UR - https://www.scopus.com/pages/publications/105021928076
U2 - 10.2147/TCRM.S553963
DO - 10.2147/TCRM.S553963
M3 - 文章
AN - SCOPUS:105021928076
SN - 1176-6336
VL - 21
SP - 1579
EP - 1591
JO - Therapeutics and Clinical Risk Management
JF - Therapeutics and Clinical Risk Management
ER -